Real-world outcomes of advanced NSCLC patients with common and uncommon/complex EGFR mutation profiles Published September 2019 Citation Riely, GJ, Lovly, CM, Messina, CGM, Bienert, S, Alexander, K, Pao, W, Magee, K, Baxi, SS, Doebele, RC. . World Conference on Lung Cancer. . Authors:Riely, GJ, Lovly, CM, Messina, CGM, Bienert, S, Alexander, K, Pao, W, Magee, K, Baxi, SS, Doebele, RC Sources:World Conference on Lung Cancer Share Posted inPublicationsUnmet need More publicationsMedical Decision MakingApril 2026Using regression discontinuity in time to strengthen real-world evidence: a case study in lung cancerChen NC, Zemplenyi AT, Adamson B, et al.Publication summaryPublicationsMethodologyNon-small cell lung cancerISPORApril 2026Impact of telemedicine encounters on survival outcomes in advanced lung cancer: A time-varying cox analysis using EHR-derived dataParatane D, Adamson B, Zemplenyi APublication summaryPublicationsNon-small cell lung cancerBlood NeoplasiaApril 2026Real-world clinical outcomes in patients with CLL previously treated with covalent BTKi and BCL2i regimensPrescott J, Parrinello C, Sawas A, et al.Publication summaryPublicationsTreatment patternsChronic lymphocytic leukemia